Amygdala Neurosciences
Latest round
- Seed
Last raised
- Jun 2017
Total raised
- $2M
Investors
- 1
About Amygdala Neurosciences
a. Amygdala Neurosciences operates as a biopharmaceutical company that focuses on the development and commercializing of therapies for addiction disorders. In May 2024, Amygdala Neurosciences, Inc. Amygdala Neurosciences is developing ANS-858, a selective, reversible inhibitor of the enzyme ALDH2, currently in preclinical development. ANS-858 is used to reduce the self-administration of addictive substances such as alcohol, nicotine, cocaine, and opiates. ANS-858 is designed to address alcohol use disorder primarily, with potential applications for smoking cessation and opioid and stimulant use disorders.
Who invested in Amygdala Neurosciences
1 investor across 1 round
See all investors in Amygdala Neurosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 8, 2017
Amount
$2M
Investors
Questions about Amygdala Neurosciences
Who invested in Amygdala Neurosciences?
Amygdala Neurosciences has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amygdala Neurosciences raised?
Amygdala Neurosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Amygdala Neurosciences last raise money?
Amygdala Neurosciences's most recent round on record is a Seed, in Jun 2017.
What does Amygdala Neurosciences do?
Amygdala Neurosciences is a biotechnology company.
Where is Amygdala Neurosciences headquartered?
Amygdala Neurosciences is headquartered in Palo Alto, US.
Which VCs invest in companies like Amygdala Neurosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Amygdala Neurosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Amygdala Neurosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.